查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1751309

更年期市场规模、份额、趋势分析报告：按治疗、地区、细分市场、预测，2025-2030 年

Menopause Market Size, Share & Trends Analysis Report By Treatment (Dietary Supplements, OTC Pharma Products), By Region (NA, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 210 Pages | 商品交期: 2-10个工作天内

价格

更年期市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球更年期市场规模预计到2030年将达到243.5亿美元，2025年至2030年的复合年增长率为5.42%。

预计停经后症候群盛行率上升、对停经相关健康问题的认识不断提高以及女性健康应用程式的广泛采用等因素将推动市场成长。

预计市场将受到越来越多的研究的推动，这些研究支持膳食补充剂优于荷尔蒙替代疗法 (HRT)。市面上有许多膳食补充剂，其中含有黑升麻、红三叶草、大豆异黄酮和龙涎香烯等成分。製造商也致力于开发新产品以应对更年期症状。例如，Morphous 已于 2023 年推出了多款补充剂产品，旨在应对更年期和更年期期间一些最紧迫的症状。首款推出的产品是 FiberUs，这是一种由瓜尔胶纤维製成的无味水溶性益生元纤维。

疫情过后，由于就诊时间延迟、荷尔蒙补充疗法再次推迟，以及成药成药的需求增加。然而，由于监管放鬆以及人们对更年期认知的不断提升，市场目前正趋于稳定。

美国食品药物核准（FDA）核准的治疗潮热和盗汗药物数量激增，也是推动市场成长的主要因素。 2023年5月，FDA核准了一种新的非荷尔蒙药物，用于治疗更年期妇女常出现的盗汗和潮热症状。这种名为fezolinethant的处方药专为无法接受荷尔蒙疗法且患有血管舒缩症状的患者（例如乳癌倖存者）设计。该药物以Veozah为品牌名销售。

更年期市场报告重点

  • 从治疗方法来看，营养保健品领域预计将在2024年占据市场主导地位，并在预测期内实现最快的成长。该领域的成长可归因于多种因素，包括老年人口的成长和创新产品的推出。例如，2021年4月，韩国营养保健品公司圃美多（Pulmuone）推出了一款含有大豆和啤酒花萃取物的产品，用于治疗更年期相关症状。
  • 非处方成药）治疗领域分为非荷尔蒙和荷尔蒙产品。更年期女性越来越多地选择非处方（OTC）荷尔蒙产品。此领域的主要产品包括局部黄体酮、Ibuprofen、脱氢表雄酮（DHEA）和褪黑激素。
  • 2024 年，北美将占据最大的销售份额。人们对饮食的认识不断提高，对老年女性特定营养需求的需求也随之增加。
  • 2022年1月，Amyris公司宣布已达成独家协议，收购MenoLabs, LLC的资产，这是一家由女性创立的公司，专注于治疗更年期症状、研究女性健康和提高大众对更年期的认识。
  • 2023年1月，女性健康品牌OPositive推出了首款更年期软糖维生素，为更年期女性提供了一种方便又美味的方式来控制她们的症状。

目录

第一章调查方法与范围

第二章执行摘要

第三章 更年期市场变数、趋势与范围

  • 市场展望
    • 母市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • COVID-19 对更年期市场影响的定性分析
  • 产品列表
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTEL分析

4. 更年期市场区隔分析（依治疗类型），2018 年至 2030 年

  • 更年期障碍市场：治疗与市场占有率趋势分析
  • 更年期市场：治疗细分仪表板
  • 营养补充品
  • 成药
    • 荷尔蒙产品
    • 非荷尔蒙产品

第五章. 按地区和治疗方法，2018-2030 年

  • 区域市场仪表板
  • 区域市场：关键要点
  • 北美洲
    • 北美膳食补充品市场
    • 北美成药市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲膳食补充剂市场
    • 欧洲成药市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 奥地利
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 亚太营养保健品市场
    • 亚太非成药市场
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
    • 台湾
    • 马来西亚
    • 新加坡
    • 越南
    • 香港
  • 拉丁美洲
    • 拉丁美洲营养保健品市场
    • 拉丁美洲成药市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • MEA营养保健品市场
    • MEA 成药市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 供应商格局
  • 公司简介
    • Bayer AG
    • Theramex
    • AbbVie, Inc.
    • Pure Encapsulations, LLC
    • Dr. Reddy's Laboratories Ltd.
    • ReNew Life Holdings Corporation
    • Padagis
Product Code: GVR-4-68039-434-2

Menopause Market Growth & Trends:

The global menopause market size is expected to reach USD 24.35 billion by 2030, registering a CAGR of 5.42% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth is expected to be driven by factors such as rising prevalence of post-menopausal syndrome, increasing awareness regarding menopause-associated health aspects, and high adoption of women's health apps.

The market is projected to be driven by rising research supporting the benefits of dietary supplements over HRT. Many dietary supplements are available in the market that contain ingredients such as black cohosh, red clover, soy isoflavones, and amberen. Manufacturers are also involved in developing new products to address menopausal symptoms. For instance, Morphus launched several supplement products in 2023 to address some of the most pressing symptoms of menopause and perimenopause. The first product launched was FiberUs, an unflavored soluble prebiotic fiber made from guar fiber.

The demand for dietary supplements and OTC pharma products increased in the post-pandemic scenario due to the delays in physician's appointments, rescheduling of hormonal replacement therapies, and the easy availability of OTC drugs from retail pharmacies and online channels. However, the market is now stabilizing due to the ease of restrictions and the increasing awareness of menopause.

The surge in FDA approvals for drugs aimed at treating hot flashes and night sweats is a significant factor propelling the growth of the market. In May 2023, the FDA gave their approval for a new non-hormonal medication to address night sweats and hot flashes that are often experienced by individuals during menopause. This prescription drug, called fezolinetant, is specifically designed for those who are unable to take hormonal therapy and who are struggling with vasomotor symptoms, such as breast cancer survivors. The medication is branded under the name Veozah.

Menopause Market Report Highlights:

  • Based on treatment, the dietary supplements treatment segment dominated the market in 2024 and is expected to witness the fastest growth during the forecast period. The growth of the segment can be attributed to several factors, including the increasing geriatric population and the launch of innovative products. For instance, in April 2021, Pulmuone, a South Korea-based dietary supplement firm, introduced a product that contains soybean and hop extracts for the treatment of menopause-related symptoms
  • The OTC pharmaceutical products treatment segment is categorized into non-hormonal and hormonal products. Women undergoing menopause are increasingly using over-the-counter (OTC) hormone products. Major products in this segment include topical progesterone, ibuprofen, Dehydroepiandrosterone (DHEA), and melatonin
  • North America held the largest revenue share in 2024. There is a growing awareness about dietary requirements, which is leading to a greater demand among older women for specific nutritional needs
  • In January 2022, Amyris, Inc. announced that it has entered into exclusive agreements to acquire the assets of a women-founded company MenoLabs, LLC. that focuses on treating menopause symptoms, conducting research of women's health and increasing society's understanding of menopause
  • In January 2023, O Positiv, a women's health brand, launched the first-ever menopause gummy vitamin, providing menopausal women with a convenient and tasty way to manage their symptoms

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Menopause Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. A growing number of women experiencing menopause
      • 3.2.1.2. Increasing awareness regarding the treatment of menopausal symptoms
      • 3.2.1.3. Innovation in products available for the management of Menopause
      • 3.2.1.4. Increasing research supporting the advantages of dietary supplements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Social stigma associated with menopause and adverse effects of products
      • 3.2.2.2. Lack of well-defined regulations
  • 3.3. Qualitative Analysis Impact of COVID-19 on Menopause Market
  • 3.4. List of Products
  • 3.5. Business Environment Analysis
    • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis

Chapter 4. Menopause Market Segment Analysis, By Treatment, 2018 - 2030 (USD Million)

  • 4.1. Menopause Market: Treatment Movement Analysis and Market Share
  • 4.2. Menopause Market: Treatment Segment Dashboard
  • 4.3. Dietary Supplements
    • 4.3.1. Dietary supplements market, 2018 - 2030 (USD Million)
  • 4.4. OTC Pharma Products
    • 4.4.1. OTC pharma products market, 2018 - 2030 (USD Million)
    • 4.4.2. Hormonal Products
      • 4.4.2.1. Hormonal products market, 2018 - 2030 (USD Million)
    • 4.4.3. Non-hormonal products
      • 4.4.3.1. Non-hormonal products market, 2018 - 2030 (USD Million)

Chapter 5. Region, By Treatment, 2018 - 2030 (USD Million)

  • 5.1. Regional Market Dashboard
  • 5.2. Regional marketplace: Key takeaways
  • 5.3. North America
    • 5.3.1. North America dietary supplements market
      • 5.3.1.1. North America dietary supplements market estimates and forecast, 2018 - 2030 (USD million)
    • 5.3.2. North America OTC pharma products market
      • 5.3.2.1. North America OTC pharma products market estimates and forecast, 2018 - 2030 (USD million)
    • 5.3.3. U.S.
      • 5.3.3.1. U.S. menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.3.3.2. U.S. dietary supplements market
        • 5.3.3.2.1. Regulatory scenario
        • 5.3.3.2.2. Competitive insights
        • 5.3.3.2.3. U.S. dietary supplements market, 2018 - 2030 (USD Million)
      • 5.3.3.3. U.S. OTC pharma products market
        • 5.3.3.3.1. Regulatory scenario
        • 5.3.3.3.2. Competitive insights
        • 5.3.3.3.3. U.S. OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.3.4. Canada
      • 5.3.4.1. Canada menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.3.4.2. Canada dietary supplements market
        • 5.3.4.2.1. Regulatory scenario
        • 5.3.4.2.2. Competitive insights
        • 5.3.4.2.3. Canada dietary supplements market, 2018 - 2030 (USD Million)
      • 5.3.4.3. Canada OTC pharma products market
        • 5.3.4.3.1. Regulatory scenario
        • 5.3.4.3.2. Competitive insights
        • 5.3.4.3.3. Canada OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.3.5. Mexico
      • 5.3.5.1. Mexico menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.3.5.2. Mexico dietary supplements market
        • 5.3.5.2.1. Regulatory scenario
        • 5.3.5.2.2. Competitive insights
        • 5.3.5.2.3. Mexico dietary supplements market, 2018 - 2030 (USD Million)
      • 5.3.5.3. Mexico OTC pharma products market
        • 5.3.5.3.1. Regulatory scenario
        • 5.3.5.3.2. Competitive insights
        • 5.3.5.3.3. Mexico OTC pharma products market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe dietary supplements market
      • 5.4.1.1. Europe dietary supplements market estimates and forecast, 2018 - 2030 (USD million)
    • 5.4.2. Europe OTC pharma products market
      • 5.4.2.1. Europe OTC pharma products market estimates and forecast, 2018 - 2030 (USD million)
    • 5.4.3. UK
      • 5.4.3.1. Canada menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.3.2. Canada dietary supplements market
        • 5.4.3.2.1. Regulatory scenario
        • 5.4.3.2.2. Competitive insights
        • 5.4.3.2.3. Canada dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.3.3. Canada OTC pharma products market
        • 5.4.3.3.1. Regulatory scenario
        • 5.4.3.3.2. Competitive insights
        • 5.4.3.3.3. Canada OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.4.4. Germany
      • 5.4.4.1. Germany menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.4.2. Germany dietary supplements market
        • 5.4.4.2.1. Regulatory scenario
        • 5.4.4.2.2. Competitive insights
        • 5.4.4.2.3. Germany dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.4.3. Germany OTC pharma products market
        • 5.4.4.3.1. Regulatory scenario
        • 5.4.4.3.2. Competitive insights
        • 5.4.4.3.3. Germany OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.4.5. France
      • 5.4.5.1. France menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.5.2. France dietary supplements market
        • 5.4.5.2.1. Regulatory scenario
        • 5.4.5.2.2. Competitive insights
        • 5.4.5.2.3. France dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.5.3. France OTC pharma products market
        • 5.4.5.3.1. Regulatory scenario
        • 5.4.5.3.2. Competitive insights
        • 5.4.5.3.3. France OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.4.6. Italy
      • 5.4.6.1. Italy menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.6.2. Italy dietary supplements market
        • 5.4.6.2.1. Regulatory scenario
        • 5.4.6.2.2. Competitive insights
        • 5.4.6.2.3. Italy dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.6.3. Italy OTC pharma products market
        • 5.4.6.3.1. Regulatory scenario
        • 5.4.6.3.2. Competitive insights
        • 5.4.6.3.3. Italy OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.4.7. Spain
      • 5.4.7.1. Spain menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.7.2. Spain dietary supplements market
        • 5.4.7.2.1. Regulatory scenario
        • 5.4.7.2.2. Competitive insights
        • 5.4.7.2.3. Spain dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.7.3. Spain OTC pharma products market
        • 5.4.7.3.1. Regulatory scenario
        • 5.4.7.3.2. Competitive insights
        • 5.4.7.3.3. Spain OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.4.8. Austria
      • 5.4.8.1. Austria menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.8.2. Austria dietary supplements market
        • 5.4.8.2.1. Regulatory scenario
        • 5.4.8.2.2. Competitive insights
        • 5.4.8.2.3. Austria dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.8.3. Austria OTC pharma products market
        • 5.4.8.3.1. Regulatory scenario
        • 5.4.8.3.2. Competitive insights
        • 5.4.8.3.3. Austria OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Norway menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.9.2. Norway dietary supplements market
        • 5.4.9.2.1. Regulatory scenario
        • 5.4.9.2.2. Competitive insights
        • 5.4.9.2.3. Norway dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.9.3. Norway OTC pharma products market
        • 5.4.9.3.1. Regulatory scenario
        • 5.4.9.3.2. Competitive insights
        • 5.4.9.3.3. Norway OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.4.10. Sweden
      • 5.4.10.1. Sweden menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.10.2. Sweden dietary supplements market
        • 5.4.10.2.1. Regulatory scenario
        • 5.4.10.2.2. Competitive insights
        • 5.4.10.2.3. Sweden dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.10.3. Sweden OTC pharma products market
        • 5.4.10.3.1. Regulatory scenario
        • 5.4.10.3.2. Competitive insights
        • 5.4.10.3.3. Sweden OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.4.11. Denmark
      • 5.4.11.1. Denmark menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.4.11.2. Denmark dietary supplements market
        • 5.4.11.2.1. Regulatory scenario
        • 5.4.11.2.2. Competitive insights
        • 5.4.11.2.3. Denmark dietary supplements market, 2018 - 2030 (USD Million)
      • 5.4.11.3. Denmark OTC pharma products market
        • 5.4.11.3.1. Regulatory scenario
        • 5.4.11.3.2. Competitive insights
        • 5.4.11.3.3. Denmark OTC pharma products market, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific dietary supplements market
      • 5.5.1.1. Asia Pacific dietary supplements market estimates and forecast, 2018 - 2030 (USD million)
    • 5.5.2. Asia Pacific OTC pharma products market
      • 5.5.2.1. Asia Pacific OTC pharma products market estimates and forecast, 2018 - 2030 (USD million)
    • 5.5.3. Japan
      • 5.5.3.1. Japan menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.3.2. Japan dietary supplements market
        • 5.5.3.2.1. Regulatory scenario
        • 5.5.3.2.2. Competitive insights
        • 5.5.3.2.3. Japan dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.3.3. Japan OTC pharma products market
        • 5.5.3.3.1. Regulatory scenario
        • 5.5.3.3.2. Competitive insights
        • 5.5.3.3.3. Japan OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.4. China
      • 5.5.4.1. China menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.4.2. China dietary supplements market
        • 5.5.4.2.1. Regulatory scenario
        • 5.5.4.2.2. Competitive insights
        • 5.5.4.2.3. China dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.4.3. China OTC pharma products market
        • 5.5.4.3.1. Regulatory scenario
        • 5.5.4.3.2. Competitive insights
        • 5.5.4.3.3. China OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.5. India
      • 5.5.5.1. India menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.5.2. India dietary supplements market
        • 5.5.5.2.1. Regulatory scenario
        • 5.5.5.2.2. Competitive insights
        • 5.5.5.2.3. India dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.5.3. India OTC pharma products market
        • 5.5.5.3.1. Regulatory scenario
        • 5.5.5.3.2. Competitive insights
        • 5.5.5.3.3. India OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.6. Australia
      • 5.5.6.1. Australia menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.6.2. Australia dietary supplements market
        • 5.5.6.2.1. Regulatory scenario
        • 5.5.6.2.2. Competitive insights
        • 5.5.6.2.3. Australia dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.6.3. Australia OTC pharma products market
        • 5.5.6.3.1. Regulatory scenario
        • 5.5.6.3.2. Competitive insights
        • 5.5.6.3.3. Australia OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. South Korea menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.7.2. South Korea dietary supplements market
        • 5.5.7.2.1. Regulatory scenario
        • 5.5.7.2.2. Competitive insights
        • 5.5.7.2.3. South Korea dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.7.3. South Korea OTC pharma products market
        • 5.5.7.3.1. Regulatory scenario
        • 5.5.7.3.2. Competitive insights
        • 5.5.7.3.3. South Korea OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.8. Thailand
      • 5.5.8.1. Thailand menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.8.2. Thailand dietary supplements market
        • 5.5.8.2.1. Regulatory scenario
        • 5.5.8.2.2. Competitive insights
        • 5.5.8.2.3. Thailand dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.8.3. Thailand OTC pharma products market
        • 5.5.8.3.1. Regulatory scenario
        • 5.5.8.3.2. Competitive insights
        • 5.5.8.3.3. Thailand OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.9. Taiwan
      • 5.5.9.1. Taiwan menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.9.2. Taiwan dietary supplements market
        • 5.5.9.2.1. Regulatory scenario
        • 5.5.9.2.2. Competitive insights
        • 5.5.9.2.3. Taiwan dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.9.3. Taiwan OTC pharma products market
        • 5.5.9.3.1. Regulatory scenario
        • 5.5.9.3.2. Competitive insights
        • 5.5.9.3.3. Taiwan OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.10. Malaysia
      • 5.5.10.1. Malaysia menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.10.2. Malaysia dietary supplements market
        • 5.5.10.2.1. Regulatory scenario
        • 5.5.10.2.2. Competitive insights
        • 5.5.10.2.3. Malaysia dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.10.3. Malaysia OTC pharma products market
        • 5.5.10.3.1. Regulatory scenario
        • 5.5.10.3.2. Competitive insights
        • 5.5.10.3.3. Malaysia OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.11. Singapore
      • 5.5.11.1. Singapore menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.11.2. Singapore dietary supplements market
        • 5.5.11.2.1. Regulatory scenario
        • 5.5.11.2.2. Competitive insights
        • 5.5.11.2.3. Singapore dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.11.3. Singapore OTC pharma products market
        • 5.5.11.3.1. Regulatory scenario
        • 5.5.11.3.2. Competitive insights
        • 5.5.11.3.3. Singapore OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.12. Vietnam
      • 5.5.12.1. Vietnam menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.12.2. Vietnam dietary supplements market
        • 5.5.12.2.1. Regulatory scenario
        • 5.5.12.2.2. Competitive insights
        • 5.5.12.2.3. Vietnam dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.12.3. Vietnam OTC pharma products market
        • 5.5.12.3.1. Regulatory scenario
        • 5.5.12.3.2. Competitive insights
        • 5.5.12.3.3. Vietnam OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.5.13. Hong Kong
      • 5.5.13.1. Hong Kong menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.5.13.2. Hong Kong dietary supplements market
        • 5.5.13.2.1. Regulatory scenario
        • 5.5.13.2.2. Competitive insights
        • 5.5.13.2.3. Hong Kong dietary supplements market, 2018 - 2030 (USD Million)
      • 5.5.13.3. Hong Kong OTC pharma products market
        • 5.5.13.3.1. Regulatory scenario
        • 5.5.13.3.2. Competitive insights
        • 5.5.13.3.3. Hong Kong OTC pharma products market, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America dietary supplements market
      • 5.6.1.1. Latin America dietary supplements market estimates and forecast, 2018 - 2030 (USD million)
    • 5.6.2. Latin America OTC pharma products market
      • 5.6.2.1. Latin America OTC pharma products market estimates and forecast, 2018 - 2030 (USD million)
    • 5.6.3. Brazil
      • 5.6.3.1. Brazil menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.6.3.2. Brazil dietary supplements market
        • 5.6.3.2.1. Regulatory scenario
        • 5.6.3.2.2. Competitive insights
        • 5.6.3.2.3. Brazil dietary supplements market, 2018 - 2030 (USD Million)
      • 5.6.3.3. Brazil OTC pharma products market
        • 5.6.3.3.1. Regulatory scenario
        • 5.6.3.3.2. Competitive insights
        • 5.6.3.3.3. Brazil OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Argentina menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.6.4.2. Argentina dietary supplements market
        • 5.6.4.2.1. Regulatory scenario
        • 5.6.4.2.2. Competitive insights
        • 5.6.4.2.3. Argentina dietary supplements market, 2018 - 2030 (USD Million)
      • 5.6.4.3. Argentina OTC pharma products market
        • 5.6.4.3.1. Regulatory scenario
        • 5.6.4.3.2. Competitive insights
        • 5.6.4.3.3. Argentina OTC pharma products market, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA dietary supplements market
      • 5.7.1.1. MEA dietary supplements market estimates and forecast, 2018 - 2030 (USD million)
    • 5.7.2. MEA OTC pharma products market
      • 5.7.2.1. MEA OTC pharma products market estimates and forecast, 2018 - 2030 (USD million)
    • 5.7.3. South Africa
      • 5.7.3.1. South Africa menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.7.3.2. South Africa dietary supplements market
        • 5.7.3.2.1. Regulatory scenario
        • 5.7.3.2.2. Competitive insights
        • 5.7.3.2.3. South Africa dietary supplements market, 2018 - 2030 (USD Million)
      • 5.7.3.3. South Africa OTC pharma products market
        • 5.7.3.3.1. Regulatory scenario
        • 5.7.3.3.2. Competitive insights
        • 5.7.3.3.3. South Africa OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.7.4. Saudi Arabia
      • 5.7.4.1. Saudi Arabia menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.7.4.2. Saudi Arabia dietary supplements market
        • 5.7.4.2.1. Regulatory scenario
        • 5.7.4.2.2. Competitive insights
        • 5.7.4.2.3. Saudi Arabia dietary supplements market, 2018 - 2030 (USD Million)
      • 5.7.4.3. Saudi Arabia OTC pharma products market
        • 5.7.4.3.1. Regulatory scenario
        • 5.7.4.3.2. Competitive insights
        • 5.7.4.3.3. Saudi Arabia OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.7.5. UAE
      • 5.7.5.1. UAE menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.7.5.2. UAE dietary supplements market
        • 5.7.5.2.1. Regulatory scenario
        • 5.7.5.2.2. Competitive insights
        • 5.7.5.2.3. UAE dietary supplements market, 2018 - 2030 (USD Million)
      • 5.7.5.3. UAE OTC pharma products market
        • 5.7.5.3.1. Regulatory scenario
        • 5.7.5.3.2. Competitive insights
        • 5.7.5.3.3. UAE OTC pharma products market, 2018 - 2030 (USD Million)
    • 5.7.6. Kuwait
      • 5.7.6.1. Kuwait menopausal women target population (45 to 60 years), 2018 - 2023 in millions
      • 5.7.6.2. Kuwait dietary supplements market
        • 5.7.6.2.1. Regulatory scenario
        • 5.7.6.2.2. Competitive insights
        • 5.7.6.2.3. Kuwait dietary supplements market, 2018 - 2030 (USD Million)
      • 5.7.6.3. Kuwait OTC pharma products market
        • 5.7.6.3.1. Regulatory scenario
        • 5.7.6.3.2. Competitive insights
        • 5.7.6.3.3. Kuwait OTC pharma products market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
  • 6.4. Company Profiles
    • 6.4.1. Bayer AG
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Theramex
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. AbbVie, Inc.
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Pure Encapsulations, LLC
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Dr. Reddy's Laboratories Ltd.
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. ReNew Life Holdings Corporation
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Padagis
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 Global menopause market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America menopause market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 7 US menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 Mexico menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 Europe menopause market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 Germany menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 13 UK menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 14 France menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Italy menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 16 Spain menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Norway menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 18 Sweden menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 Denmark menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific menopause market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 22 China menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 Japan menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 24 India menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Australia menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 26 South Korea menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Thailand menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 28 Latin America menopause market, by country, 2018 - 2030 (USD Million)
  • Table 29 Latin America menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 Brazil menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Argentina menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa menopause market, by country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 34 South Africa menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 UAE menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 37 Kuwait menopause market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 List of products containing. Rheum Raponticum (Siberian Rhubarb Root), Soy isoflavones, Black Cohosh, Red Clover and Amberen
  • Table 39 Regulatory scenario for new product approval in Mexico
  • Table 40 Regulations for health food filing and registration in China
  • Table 41 New health food filing system in China
  • Table 42 Regulatory scenario for new product approval in Brazil

List of Figures

  • Fig. 1 Menopause market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Menopause market snapshot
  • Fig. 10 Menopause market segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Menopause market: Parent market outlook
  • Fig. 13 Menopause market: Ancillary market outlook
  • Fig. 14 Menopause market dynamics
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Menopause market: Porter's five forces analysis
  • Fig. 18 Menopause market: PESTLE analysis
  • Fig. 19 Menopause market treatment outlook: Key takeaways
  • Fig. 20 Menopause market: Treatment movement analysis, 2024 & 2030
  • Fig. 21 Menopause dietary supplements market, 2018 - 2030 (USD Million)
  • Fig. 22 Menopause OTC pharma products market, 2018 - 2030 (USD Million)
  • Fig. 23 Menopause hormonal products market, 2018 - 2030 (USD Million)
  • Fig. 24 Menopause non-hormonal products market, 2018 - 2030 (USD Million)
  • Fig. 25 Menopause market revenue, by region
  • Fig. 26 Regional key marketplace takeaways
  • Fig. 27 Regional key marketplace takeaways
  • Fig. 28 North America dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 North America OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 31 U.S. dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Canada menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 34 Canada dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Canada OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 37 Mexico dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Europe dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Europe OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 UK menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 42 UK dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 UK OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 45 Germany dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Germany OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 France menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 48 France dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 France OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Italy menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 51 Italy dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Italy OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Spain menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 54 Spain dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Spain OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Austria menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 57 Austria dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Austria OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark menopausal women target population (45 to 60 years), 2018 - 2023 in Million
  • Fig. 60 Denmark dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Denmark OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Sweden menopausal women target population (45 to 60 years), 2018 - 2023 in Million
  • Fig. 63 Sweden dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Norway menopausal women target population (45 to 60 years), 2018 - 2023 in Million
  • Fig. 66 Norway dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Norway OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Japan menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 71 Japan dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Japan OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 China menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 74 China dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 China OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 India menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 77 India dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 India OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 South Korea menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 80 South Korea dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Australia menopausal women target population (45 to 60 years), 2018 - 2023 in Million
  • Fig. 83 Australia dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Australia OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Thailand menopausal women target population (45 to 60 years), 2018 - 2023 in Million
  • Fig. 86 Thailand dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Thailand OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Taiwan menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 89 Taiwan dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Taiwan OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Malaysia menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 92 Malaysia dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Malaysia OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Singapore menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 95 Singapore dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Singapore OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Vietnam menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 98 Vietnam dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Vietnam OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Hong Kong menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 101 Hong Kong dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Hong Kong OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Latin dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Latin America OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Brazil menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 106 Brazil dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Brazil OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Argentina menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 109 Argentina dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 110 Argentina OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 MEA dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 MEA OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 South Africa menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 114 South Africa dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 South Africa OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 116 Saudi Arabia menopausal women target population (45 to 60 years), 2018 - 2023 in Million
  • Fig. 117 Saudi Arabia dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 118 Saudi Arabia OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 119 UAE menopausal women target population (45 to 60 years), 2018 - 2023 in Million
  • Fig. 120 UAE dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 121 UAE OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 122 Kuwait menopausal women target population (45 to 60 years), 2018 - 2023 in millions
  • Fig. 123 Kuwait dietary supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 124 Kuwait OTC pharma products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Company categorization
  • Fig. 126 Company market position analysis
  • Fig. 127 Strategy mapping